News

February 2014

A cure for diabetes could just be skin-deep: UCSF, Gladstone Institutes scientists grow healthy beta cells -
Collaborating with researchers from the Gladstone Institutes in San Francisco,  Matthias Hebrok, PhD,  director of the Diabetes Center at the University of California, San Francisco,  co-authored a ground-breaking study this week on reprogramming skin cells into insulin-producing pancreas cells – a major step toward finding a cure for type 1 diabetes.
UCSF Scientists Receive Grant to Continue Stem Cell Research for Diabetes Cure: Funds will enable further research for treating type 1 diabetes -
This week, the California Institute for Regenerative Medicine awarded two members of the University of California, San Francisco Diabetes Center -- immunologist Mark Anderson, MD, PhD, and stem cell researcher Matthias Hebrok, PhD -- a grant to continue their breakthrough research on thymic cells, a key component to the immune system.

January 2014

Progress Continues in Islet Transplantation, Immunosuppression Alternatives & New Sources of Cells -
At the 14th World Congress of the International Pancreas and Islet Transplant Association (IPITA), UCSF faculty presented the latest in islet transplantation, and shared exciting progress in stopping islet and tissue rejection through regulatory T cells (Tregs) and creating new sources of insulin-producing beta cells.
Diabetes Center Researcher Identifies Gene Responsible for Control of Brown Fat Development -
Shingo Kajimura, PhD, a Diabetes Center at UCSF faculty member and a member of the UCSF Department of Cell and Tissue Biology, has identified a gene vital to the development and function of brown fat cells.
Behavioral Study Proves that Diabetes Distress is Highly Responsive to Intervention -
A recent study in non-clinically depressed adults with type 2 diabetes compared three interventions to reduce Diabetes Distress and improve self-management.
UCSF Launches GleeT1D - New Clinical Trial for Type 1 Diabetes Patients Diagnosed Within 100 Days -
 A new, phase II clinical trial is being launched to evaluate the safety and efficacy of imatinib as a novel therapy for new-onset type 1 diabetes.

November 2013

Type 1 Diabetes Drug Effective In Stopping Beta Cell Destruction -
An experimental drug that has been studied for nearly 20 years continues to show effectiveness in about half of the patients who participated in a recent phase 2 clinical trial.
New Immune Cell Discovery to Impact Autoimmune Diseases -
Mark Anderson, MD, PhD, and his colleagues have discovered a distinctive type of immune cell called an eTAC, which puts a damper on immune responses and could eventually lead to more effective treatments for autoimmune diseases including type 1 diabetes.
Free Diabetes Education Now Available Online Through Coursera -
Coursera, one of the leading providers of MOOCs (or massive open online courses) is now offering a free course on diabetes taught by faculty members from throughout UCSF’s professional schools: Medicine, Nursing, Pharmacy and Dentistry.
Faculty Member Pursues New Cell Messaging Research -
RNA specialist, Michael McManus, PhD, received an NIH grant to explore and enhance our understanding of a recently discovered cell-to-cell messaging process called extracellular (outside the cell) RNA communication -- exRNA.
 
//